- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02317328
Imagerie rétinienne par optique adaptative
Background:
- By the time diseases of the retina are detected, serious damage has often already been done. Researchers want to find better ways of viewing the retina. One way called adaptive optics may help detect problems earlier.
Objectives:
- To study if adaptive optics can help find better ways to diagnose, treat, and manage retinal diseases.
Eligibility:
- People over age 12 with an eye disease.
- Healthy volunteers over age 12.
Design:
- Participants will be screened with medical history and eye exams. These may include dilating pupils and taking pictures of the eyes.
- Participants will have 1 or more study visits. They will have:
- Medical and eye history.
- Questions about their medications.
- Eye exam including pupil dilation.
- Adaptive optics imaging. After dilation, participants sit still while looking into an adaptive optics instrument. They look at specific places and images are taken of their retina.
- They may also have:
- More images.
- Perimetry. Participants look into a lens and press a button when they see a light.
- Color vision tests.
- Electroretinogram. Participants will get numbing eye drops and special contact lenses. A small metal electrode will be put on their forehead. They will look at flashing lights and try not to blink.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Objective: The objective of this protocol is to collect and assess adaptive optics (AO) retinal images of normal and diseased eyes.
Study Population: Three hundred and fifty (350) participants with eye diseases and 250 normal volunteers will be enrolled.
Design: This is an observational protocol which will enroll 350 participants with various eye diseases and 250 age-matched healthy volunteers over five years. In general, participants will undergo a complete ophthalmic examination including assessments of visual acuity, intraocular pressure, and a dilated ocular examination. Imaging will be performed using adaptive optics instruments deployed in the NEI Eye Clinic.
Outcome Measures: The primary outcome for this protocol is qualitative and quantitative assessment of the AO images with comparisons of normal and diseased states.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Daniel W Claus, R.N.
- Numéro de téléphone: (301) 451-1621
- E-mail: daniel.claus@nih.gov
Sauvegarde des contacts de l'étude
- Nom: Johnny C Tam, Ph.D.
- Numéro de téléphone: (301) 435-7821
- E-mail: johnny.tam@nih.gov
Lieux d'étude
-
-
Maryland
-
Bethesda, Maryland, États-Unis, 20892
- Recrutement
- National Institutes of Health Clinical Center
-
Contact:
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
- Numéro de téléphone: TTY dial 711 800-411-1222
- E-mail: ccopr@nih.gov
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
500 participants with eye diseases and 500 healthy volunteers will be enrolled.
La description
- INCLUSION CRITERIA:
Participants will be eligible if they:
- Are 12 years of age or older.
- Have the ability to cooperate with an eye exam and adaptive optics imaging.
- Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
- Have an eye disease or are a healthy volunteer with a normal eye exam (no visually-significant eye findings on examination).
EXCLUSION CRITERIA:
Participants will not be eligible if:
-They have a condition which prevents adequate images from being obtained (e.g. unstable fixation or media opacity).
EXCLUSION CRITERIA FOR FLUORESCEIN AND/OR INDOCYANINE GREEN IMAGING
Partaicipants are not eligible for fluorescein and/or indocyanine green imaging if they:
- Are under 18 years of age.
- For participants who will undergo fluorescein imaging have a history of adverse reaction to fluorescein.
- For participants who will undergo indocyanine green imaging have a history of adverse reaction to indocyanine green dye, know or suspected allergies to iodine or shellfish.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: CASE_CONTROL
- Perspectives temporelles: CROSS_SECTIONAL
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Healthy Volunteers
Healthy volunteers |
|
Affected participants
Participants with ocular conditions |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Qualitative and quantitative assessment of AO images
Délai: ongoing
|
Qualitative and quantitative assessment of AO images with comparison of normal and diseased states. |
ongoing
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Johnny C Tam, Ph.D., National Eye Institute (NEI)
Publications et liens utiles
Publications générales
- Hendrickson A, Drucker D. The development of parafoveal and mid-peripheral human retina. Behav Brain Res. 1992 Jul 31;49(1):21-31. doi: 10.1016/s0166-4328(05)80191-3.
- Wing GL, Blanchard GC, Weiter JJ. The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1978 Jul;17(7):601-7.
- Fotedar R, Wang JJ, Burlutsky G, Morgan IG, Rose K, Wong TY, Mitchell P. Distribution of axial length and ocular biometry measured using partial coherence laser interferometry (IOL Master) in an older white population. Ophthalmology. 2010 Mar;117(3):417-23. doi: 10.1016/j.ophtha.2009.07.028. Epub 2010 Jan 19.
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimé)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 150020
- 15-EI-0020
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .